|
|||||
|
|
Effects of short-acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes |
|
| Authors: | Nicklas J. Johansen MD Thomas F. Dejgaard MD Asger Lund MD Camilla Schlüntz BMSc Bolette Hartmann PhD Jens J. Holst MD Tina Vilsbøll MD Henrik U. Andersen MD Filip K. Knop MD |
| Affiliation: | 1. Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark;2. Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;3. Steno Diabetes Center Copenhagen, Gentofte, Denmark |
| Abstract: | |
| Keywords: | antidiabetic drug clinical trial exenatide GLP-1 receptor agonist randomized trial type 1 diabetes |